We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The American Society of Anesthesiologists (ASA) Annual Meeting will feature 62 scientific presentations that reference BIS® monitoring when it convenes on October 17-21, 2009 in...
Attorney Advertising. Notice is hereby given that Stull, Stull & Brody has commenced an investigation on behalf of shareholders of Aspect Medical Systems, Inc. (“Aspect Medical”...
Levi & Korsinsky is investigating the Board of Directors of Aspect Medical Systems, Inc. (“Aspect Medical” or the “Company”) (NasdaqGS: ASPM) for possible breaches of fiduciary...
Covidien (NYSE: COV) and Aspect Medical Systems, Inc. (NASDAQ: ASPM) today announced that Covidien has reached a definitive agreement to acquire Aspect, a global market leader...
Aspect Medical Systems, Inc. (NASDAQ: ASPM) today announced that two companion articles highlighting results from the BRITE-MD (Biomarkers for Rapid Identification of...
Aspect Medical Systems, Inc. (NASDAQ: ASPM), reported today that worldwide sensor revenue was $21.5 million for Q2 2009, a 1% increase from $21.4 million in Q2 2008 and total...
Aspect Medical Systems, Inc. (NASDAQ: ASPM) today announced that it has signed an exclusive U.S. distribution and technology licensing agreement with LiDCO Group Plc (AIM: LID...
Aspect Medical Systems, Inc. (NASDAQ: ASPM) today announced a five year comparative effectiveness research collaboration with Cleveland Clinic focused on improving patient...
Aspect Medical Systems, Inc. (NASDAQ: ASPM) will report earnings results for the 2009 second quarter on Wednesday, July 29, 2009. Following the earnings announcement that day...
Aspect Medical Systems, Inc. (NASDAQ: ASPM): Highlights of Q1 2009 Compared with Q1 2008 Sensor revenue increased 5% to $21.6 million Total revenue increased 4...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions